Press release, 16 February 2022 at 12 p.m. (EET)
Nightingale Health Plc will publish its half-year report for July – December 2021 on 24 February 2022 at around 9 a.m. EET. The materials will be made available soon after publication at www.nightingalehealth.com/investors.
Nightingale will arrange a live webcast for investors and media in English on 24 February 2022 at 1 p.m. EET. You can watch the webcast online at https://nightingalehealth.videosync.fi/2021-2022-h1-results.
A presentation will be held by CEO Teemu Suna and CFO Tuukka Paavola. A recording of the event will be available later the same day at www.nightingalehealth.com/investors.
For further information, please contact
Teemu Suna, CEO
Nightingale Health is a Finnish health technology company that aims to promote preventative health and help people stay healthy. Our blood analysis technology measures a large variety of biomarkers from a single blood sample and identifies personal risks for disease using unique health data assets. We provide people with comprehensive insights on health, help them make better decisions regarding their health and connect them with healthcare experts that offer preventative services for maintaining health. We strive to help millions of people prevent common lifestyle diseases in the future and, at the same time, to reduce the immense expenses of healthcare.